CNMD CONMED Corp

Price (delayed)

$94.07

Market cap

$2.78B

P/E Ratio

40.72

Dividend/share

$0.8

EPS

$2.31

Enterprise value

$3.47B

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, ...

Highlights
The stock's price to earnings (P/E) is 90% less than its 5-year quarterly average of 398.5 and 38% less than its last 4 quarters average of 66.1
CONMED's gross profit has increased by 23% YoY
The company's debt rose by 4.5% QoQ but it fell by 4% YoY

Key stats

What are the main financial stats of CNMD
Market
Shares outstanding
29.53M
Market cap
$2.78B
Enterprise value
$3.47B
Valuations
Price to earnings (P/E)
40.72
Price to book (P/B)
3.5
Price to sales (P/S)
2.71
EV/EBIT
31.26
EV/EBITDA
27.37
EV/Sales
3.4
Earnings
Revenue
$1.02B
EBIT
$110.95M
EBITDA
$126.72M
Free cash flow
$74.31M
Per share
EPS
$2.31
Free cash flow per share
$2.53
Book value per share
$26.85
Revenue per share
$34.67
TBVPS
$23.95
Balance sheet
Total assets
$1.79B
Total liabilities
$996.18M
Debt
$715.77M
Equity
$789.55M
Working capital
$300.7M
Liquidity
Debt to equity
0.91
Current ratio
2.6
Quick ratio
1.11
Net debt/EBITDA
5.45
Margins
EBITDA margin
12.4%
Gross margin
56.4%
Net margin
6.6%
Operating margin
10.9%
Efficiency
Return on assets
3.8%
Return on equity
8.8%
Return on invested capital
9.5%
Return on capital employed
6.9%
Return on sales
10.9%
Dividend
Dividend yield
0.85%
DPS
$0.8
Payout ratio
34.6%

CNMD stock price

How has the CONMED stock price performed over time
Intraday
3.1%
1 week
5.78%
1 month
-14.37%
1 year
-33.4%
YTD
-33.64%
QTD
-36.67%

Financial performance

How have CONMED's revenue and profit performed over time
Revenue
$1.02B
Gross profit
$575.58M
Operating income
$110.95M
Net income
$67.66M
Gross margin
56.4%
Net margin
6.6%
The operating income has soared by 111% year-on-year and by 2.2% since the previous quarter
The operating margin has surged by 82% year-on-year
CONMED's gross profit has increased by 23% YoY
CNMD's revenue is up by 16% year-on-year

Growth

What is CONMED's growth rate over time

Valuation

What is CONMED stock price valuation
P/E
40.72
P/B
3.5
P/S
2.71
EV/EBIT
31.26
EV/EBITDA
27.37
EV/Sales
3.4
The stock's price to earnings (P/E) is 90% less than its 5-year quarterly average of 398.5 and 38% less than its last 4 quarters average of 66.1
CNMD's EPS is up by 8% QoQ
The stock's price to book (P/B) is 34% less than its last 4 quarters average of 5.3 and 5% less than its 5-year quarterly average of 3.7
CNMD's equity is up by 9% YoY
CNMD's P/S is 34% less than its last 4 quarters average of 4.1 and 7% less than its 5-year quarterly average of 2.9
CNMD's revenue is up by 16% year-on-year

Efficiency

How efficient is CONMED business performance
CNMD's return on invested capital has surged by 111% year-on-year
CNMD's ROS has soared by 82% YoY
CNMD's return on assets is up by 6% since the previous quarter
The ROE has grown by 6% from the previous quarter

Dividends

What is CNMD's dividend history
DPS
$0.8
Dividend yield
0.85%
Payout ratio
34.6%
Recent dividends

Financial health

How did CONMED financials performed over time
CNMD's total assets is 79% greater than its total liabilities
The current ratio has grown by 12% YoY and by 11% from the previous quarter
CNMD's quick ratio is up by 7% QoQ
The company's debt is 9% lower than its equity
The company's debt to equity fell by 12% YoY but it rose by 4.6% QoQ
CNMD's equity is up by 9% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.